Daily non-political popular news in brief.
Scientists move closer to developing a new class of asthma and allergy drugs
02-14-2008 · EurekAlert!A team of scientists has moved closer to developing a new class of effective asthma and allergy drugs. With new research published today the team has found an important target that holds significant promise for millions of people suffering from allergies, asthma, rheumatoid arthritis and a range of other inflammatory diseases. This work confirms that a key component of the body's own response to allergens can be targeted to reduce allergic reactions in mice.
Read more »
Keywords: scientists, move, developing, class, asthma, allergy, drugs, scientist, drug
« Previous | Next »
Similar news on "Scientists move closer to developing a new class of asthma and allergy drugs":
- New alzheimer's drug shows promise in clinical trial
11-02-2006 · EurekAlert!
The only drugs currently available for Alzheimer's patients are those that alleviate symptoms, but a team of scientists led by Paul Aisen, MD, director of the Memory Disorders program at Georgetown University Medical Center, is testing a new class of drugs that actually target the molecule believed to cause the disease.
Similar news · Read more »
- HIV drug resistance risk in mothers reduced by combination of common drugs
11-09-2007 · EurekAlert!
Adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options.Providing tenofovir and emtricitabine with nevirapine during labor greatly reduces the extent of resistance to non-nucleoside reverse transcriptate inhibitors, such as nevirapine, which HIV-positive women take to lower the risk of mother-to-child transmission during childbirth.
Similar news · Read more »
- New computational technique can predict drug side effects
12-11-2007 · EurekAlert!
Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process. Now researchers at the University of California-San Diego have developed a novel technique using computer modeling to identify potential side effects of pharmaceuticals, and have used the technique to study a class of drugs that includes tamoxifen.
Similar news · Read more »
- Virtual human in HIV drug simulation
01-29-2008 · EurekAlert!
The combined supercomputing power of the UK and US 'national grids' has enabled UCL scientists to simulate the efficacy of an HIV drug in blocking a key protein used by the lethal virus. The method -- an early example of the Virtual Physiological Human in action -- could one day be used to tailor personal drug treatments, for example for HIV patients developing resistance to their drugs.
Similar news · Read more »
- Plant pathogen yields substance to fight neuroblastoma
01-17-2008 · EurekAlert!
Drug treatment of neuroblastoma, a tumor of the nervous system in children, poses major problems. Therefore, scientists at the German Cancer Research Center have been searching for substances that are suitable as a basis for developing better drugs. Now they have found a candidate: HC-toxin, which is isolated from a fungal plant pathogen. The substance from the maize pathogen reprograms neuroblastoma cells in such a way that they behave almost like healthy cells again.
Similar news · Read more »
- Enzyme critical for early growth of abdominal aortic aneurysms
02-13-2007 · EurekAlert!
Surgery is the only treatment for an abdominal aortic aneurysm, a weak spot in the body's main artery that dilates dangerously over time. If the vessel ruptures suddenly before surgery to repair it, a quick death is virtually certain. Now, scientists say they have identified a key enzyme that triggers chronic inflammation in the aorta and promotes the growth of aneurysms. Their finding raises hopes for developing a drug that could prevent small aneurysms from enlarging to the point where surgery is necessary.
Similar news · Read more »
- Does a component of niacin point the way to anti-aging drugs?
02-08-2007 · EurekAlert!
In recent years, scientists have discovered that a family of enzymes called sirtuins can dramatically extend life in organisms as diverse as yeast, worms and flies. A number of scientific groups and biotechnology companies are eagerly searching for drug candidates able to boost sirtuin activity, hoping to develop an "anti-aging" drug. Now, a new study from scientists at the Wistar Institute points to another strategy for activating sirtuins to unleash their anti-aging powers.
Similar news · Read more »
- Diabetes drug dramatically boosts power of platinum chemotherapy
05-07-2007 · EurekAlert!
A widely used diabetes drug dramatically boosted the potency of platinum-based cancer drugs when administered together to a variety of cancer cell lines and to mice with tumors, scientists from Dana-Farber Cancer Institute report.
Similar news · Read more »
- Physician-scientist urges improved drug regulation to ensure heart safety of non-heart drugs
12-28-2007 · EurekAlert!
Current regulatory policies should be strengthened to ensure acceptable cardiovascular safety of drugs developed primarily for non-cardiovascular medical problems, according to a recent presentation made by Dr. Jeffrey Borer, an authority in cardiovascular medicine and surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City.
Similar news · Read more »
- Drugs for Parkinson's disease may ease stroke-related disability
04-03-2007 · EurekAlert!
Scientists have untangled two similar disabilities that often afflict stroke patients, in the process revealing that one may be treatable with drugs for Parkinson's disease. Researchers at Washington University School of Medicine in St. Louis showed that stroke damage in a brain region known as the putamen is strongly linked to motor neglect, a condition that makes patients slow to move toward the left side.
Similar news · Read more »
